OUTCOMES OF FIRST LINE BEVACIZUMAB-BASED CHEMOTHERAPY FOR NSCLC RELATIVE TO THE MEDICATIONS USED TO CONTROL HYPERTENSION (HTN).
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
Bevacizumab,hypertension,angiotensin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要